2-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-8-[4(trifluoromethoxy)benzenesulfonyl]-1,4-dioxa-8-azaspiro[4.5]decane

ID: ALA3342869

PubChem CID: 118716716

Max Phase: Preclinical

Molecular Formula: C26H32F3N3O6S

Molecular Weight: 571.62

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1

Standard InChI:  InChI=1S/C26H32F3N3O6S/c1-35-24-5-3-2-4-23(24)31-16-14-30(15-17-31)18-21-19-36-25(37-21)10-12-32(13-11-25)39(33,34)22-8-6-20(7-9-22)38-26(27,28)29/h2-9,21H,10-19H2,1H3

Standard InChI Key:  QCESWGLBLOFLSN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    3.1449  -24.7427    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5577  -25.4526    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9661  -24.7402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6504  -26.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8404  -27.5341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6579  -27.5987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9748  -26.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3506  -26.3107    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2554  -25.8786    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2342  -26.6996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9328  -27.1264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6737  -25.9153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9753  -25.4843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0885  -28.2999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9095  -28.2791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3318  -28.9801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1493  -28.9614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5478  -28.2411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1183  -27.5380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2946  -27.5553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3658  -28.2222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7890  -28.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6094  -28.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0075  -28.1882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5751  -27.4831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7561  -27.5039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3304  -26.8023    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.7216  -26.0848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8404  -25.8443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1469  -25.4171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4301  -25.8077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4098  -26.6256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1124  -27.0511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8264  -26.6580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6929  -27.0179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6743  -27.8348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0426  -28.2271    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3724  -28.2595    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.6686  -28.6512    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  9 10  1  0
  9 13  1  0
 10 11  1  0
 11  4  1  0
  4 12  1  0
 12 13  1  0
  6 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 26 27  1  0
 27 28  1  0
  9  2  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 32 35  1  0
 35 36  1  0
 36 37  1  0
 36 38  1  0
 36 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3342869

    ---

Associated Targets(Human)

ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 571.62Molecular Weight (Monoisotopic): 571.1964AlogP: 3.31#Rotatable Bonds: 7
Polar Surface Area: 80.78Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.32CX LogP: 4.78CX LogD: 4.52
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.50Np Likeness Score: -1.28

References

1. Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L..  (2014)  Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors.,  87  [PMID:25261823] [10.1016/j.ejmech.2014.09.070]

Source